Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Conjugated and Synergistic Therapies in the treatment of Covid 19 Dysfunction - Pain, Weakness, Parestheria, Respiratory Condition, Memory, Olfactory and Taste: Case Series

Vitor Hugo Panhoca, Antonio Eduardo de Aquino Junior, Tiago Zuccolotto Rodrigues, Vanessa Garcia, Gabriely Simao, Fernanda Mansano Carbinatto, Lais Tatiane Ferreira, Viviane Brocca de Souza, Alannah Rodrigues Kohl, Jéssica Altíssimo Gontijo Alberto, Jacqueline Ferreira Guimaraes, Vitória Gomes da Silva, Vanderlei Salvador Bagnato

The global pandemic of Sars-Cov-2 promoted 566 million infected and more than 6.3 million deaths, around the world. However, after infection, sequelae may appear, often persisting for more than 12 weeks, called post-COVID 19 sequelae, of systemic origin (fatigue and asthenia), respiratory (dyspnea and persistent cough), neuropsychiatric (memory loss, imbalance, anosmia, ageusia and anxiety) and musculoskeletal (myalgia and joint pain). In this context, new technologies and methodologies are developed for the treatment of these sequelae, often with the synergistic use of photonic, ultrasonic and negative pressure resources. In this work, 4 cases of patients with post-Covid 19 sequelae were gathered, from the most varied origins. They were followed up in evolution, varying the number of treatment sessions from case to case. The treatment carried out through these non-invasive and non-drug resources (laser, ultrasound and negative pressure) enabled the complete rehabilitation of these patients, returning their quality of life.